Annis Gardner Whiting Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 136 shares of GILD stock, worth $11,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136
Previous 97
40.21%
Holding current value
$11,934
Previous $6.66 Million
71.32%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,924Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.72 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.42 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.28 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...